SCHEMBL8990514

SCHEMBL8990514

CS(=O)(=O)Cc1ccc2[nH]ccc2c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EPHX2 P34913 1/20 0.53
▸ PPARG P37231 1/20 0.53
▸ CYP19A1 P11511 1/20 0.48
▸ KDM4E B2RXH2 1/20 0.46
▸ MAPT P10636 1/20 0.46
▸ CA12 O43570 1/20 0.44
▸ CA1 P00915 1/20 0.44
▸ CA2 P00918 1/20 0.44
▸ CA9 Q16790 1/20 0.44
▸ MTOR P42345 3/20 0.44
▸ PIK3CA P42336 2/20 0.44
▸ CYP2C9 P11712 1/20 0.44
▸ ATR Q13535 1/20 0.44
▸ HDAC1 Q13547 1/20 0.43
▸ HDAC8 Q9BY41 1/20 0.43
▸ CYP2A6 P11509 2/20 0.43
▸ AHR P35869 3/20 0.43
▸ NR4A2 P43354 2/20 0.43
▸ F7 P08709 1/20 0.43
▸ LTA4H P09960 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9275073 0.85 CYP19A1 (0.47) EPHX2PPARGCYP19A1KDM4EMAPT
SCHEMBL28853829 0.83 PTGS2 (0.53) EPHX2PPARGCYP19A1CA12CA1
SCHEMBL1650589 0.83 CA1 (0.51) EPHX2PPARGCYP19A1KDM4EMAPT
SCHEMBL30155019 0.83 CA1 (0.51) EPHX2PPARGCYP19A1KDM4EMAPT
SCHEMBL5918472 0.82 CYP19A1 (0.55) EPHX2PPARGCYP19A1KDM4EMAPT
SCHEMBL10753454 0.79 NFATC1 (0.61) EPHX2PPARGCYP19A1KDM4EMAPT
Sulfuric Acid SCHEMBL1491064 0.79 CA1 (0.48) EPHX2PPARGCYP19A1KDM4EMAPT
Sulfuric Acid SCHEMBL9705330 0.79 CYP19A1 (0.51) EPHX2PPARGCYP19A1KDM4EMAPT
SCHEMBL27955199 0.76 CYP19A1 (0.46) EPHX2PPARGCYP19A1KDM4EMAPT
SCHEMBL9772878 0.76 HDAC1 (0.48) EPHX2PPARGCYP19A1KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5583149-A TREATING VASCULAR HEADACHES BRISTOL-MYERS SQUIBB COMPANY (US) 1996-12-10 — — US disclosed
US-5468768-A FOR TREATING VASCULAR HEADACHES BRISTOL-MYERS SQUIBB COMPANY (US) 1995-11-21 — — US disclosed
EP-0666258-A1 Indolylcycloaklanylamin- und Indolylcycloalkenylamine derivatives, their preparation and their use as anti-migraine agents Bristol-Myers Squibb Company (US) 1995-08-09 — — EP disclosed
Send feedback